Endpoint definition
↥Name | I9_HEARTFAIL_AND_ANTIHYPERT |
---|---|
Long name | Heart failure and antihypertensive medication |
Conditions required | RX_ANTIHYP |
Include | I9_HEARTFAIL |
First defined in version | DF5 |
Name | I9_HEARTFAIL_AND_ANTIHYPERT |
---|---|
Long name | Heart failure and antihypertensive medication |
Conditions required | RX_ANTIHYP |
Include | I9_HEARTFAIL |
First defined in version | DF5 |
All | Female | Male | |
---|---|---|---|
Number of individuals | 22113 | 10443 | 11670 |
Unadjusted prevalence (%) | 10.19 | 8.50 | 12.40 |
Mean age at first event (years) | 65.74 | 65.71 | 65.77 |
Case fatality at 5-years (%) | 12.02 | 9.40 | 14.35 |
All | Female | Male | |
---|---|---|---|
Median nb. of events per indiv. | 4.0 | 4.0 | 5.0 |
Recurrence at 6 months (%) | 64.61 | 61.66 | 67.69 |
before Heart failure and antihypertensive medication
after Heart failure and antihypertensive medication
Loading survival analyses plot…
Loading survival analyses table…